Last reviewed · How we verify
NCT06313359
Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.
trial in Peripheral Neuropathy Due to Chemotherapy in 40 participants. Currently enrolling.
30 December 2025
Quick facts
| Lead sponsor | Texas Woman's University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 30 March 2024 |
| Primary completion | 30 December 2025 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across United States |
Conditions studied
- Peripheral Neuropathy Due to Chemotherapy — all drugs for Peripheral Neuropathy Due to Chemotherapy →
Sponsor
Texas Woman's University
Who can join
18 and older, any sex, with Peripheral Neuropathy Due to Chemotherapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06313359
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peripheral Neuropathy Due to Chemotherapy
Currently open trials in the same condition.
- NCT07423390 — Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy · Phase 3 · recruiting
- NCT06807294 — Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT) · NA · recruiting
- NCT06744816 — Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Sin · EARLY_PHASE1 · recruiting
- NCT07167446 — Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy · EARLY_PHASE1 · recruiting
- NCT06616649 — Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study. · NA · recruiting
Other Texas Woman's University trials
Trials by the same sponsor.
- NCT05074849 — Benefits of Insoles With Real-Time Alert and Foot Self-Care Education · NA · not yet recruiting
- NCT07493954 — Eat Healthy Grow Healthy Program to Promote Fruit and Vegetable Intake in Preschoolers · NA · active not recruiting
- NCT07020897 — Short-term and Intermediate-term Effects of Self-applied Joint Mobilization Versus Clinician-applied Joint Mobilization · NA · not yet recruiting
- NCT07130539 — Mediterranean-DASH Intervention for Neurodegenerative Delay and High-Intensity Interval Training in Adults With Hyperten · NA · active not recruiting
- NCT06705634 — How Dry Needling at the Neck Affects Shoulder Movement, Strength, Pain, and Shoulder Circulation · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06313359 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas Woman's University
- Last refreshed: 3 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06313359.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing